Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuma Tsuboi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Chembiochem : a European Journal of Chemical Biology|June 7, 2024
The Post-Polyketide Synthase Modification Mechanism in Hitachimycin BiosynthesisFumitaka Kudo, Kazuma Tsuboi, Mutsumi Ikezaki, et al.
IJU Case Reports|July 5, 2023
A case of mucosal-associated lymphoid tissue lymphoma of the urachusKazuma Tsuboi, Kensuke Bekku, Kohei Haisa, et al.
Chembiochem : a European Journal of Chemical Biology|January 5, 2023
Acyltransferase Domain Exchange between Two Independent Type I Polyketide Synthases in the Same Producer Strain of Macrolide AntibioticsFumitaka Kudo, Kosuke Kishikawa, Kazuma Tsuboi, et al.
IJU Case Reports|December 29, 2025
Multiple Bone Metastases From Non-Muscle Invasive Bladder Cancer Responding to Combination Therapy With Enfortumab Vedotin and Pembrolizumab: A Case ReportShin Kanemoto, Shinkuro Yamamoto, Kosuke Hino, et al.
Acta Medica Okayama|April 30, 2025
Clinical Outcomes of Neoadjuvant Paclitaxel/Cisplatin/Gemcitabine Compared with Gemcitabine/Cisplatin for Muscle-Invasive Bladder CancerTatsushi Kawada, Yasuyuki Kobayashi, Takuji Tsugawa, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2016
Structural optimization and structure-functional selectivity relationship studies of G protein-biased EP2 receptor agonistsSeiji Ogawa, Toshihide Watanabe, Kazumi Moriyuki, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of G Protein-Biased EP2 Receptor AgonistsSeiji Ogawa, Toshihide Watanabe, Isamu Sugimoto, et al.
Scientific Reports|July 27, 2025
Eosinophils as a predictive marker of treatment-related adverse events in mRCC patients treated with first-line immune-checkpoint inhibitor combination therapyTatsushi Kawada, Satoshi Katayama, Takafumi Yanagisawa, et al.
Urologic Oncology|December 21, 2023
Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumabSatoshi Katayama, Takehiro Iwata, Tasushi Kawada, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Chembiochem : a European Journal of Chemical Biology|June 7, 2024
The Post-Polyketide Synthase Modification Mechanism in Hitachimycin BiosynthesisFumitaka Kudo, Kazuma Tsuboi, Mutsumi Ikezaki, et al.
IJU Case Reports|July 5, 2023
A case of mucosal-associated lymphoid tissue lymphoma of the urachusKazuma Tsuboi, Kensuke Bekku, Kohei Haisa, et al.
Chembiochem : a European Journal of Chemical Biology|January 5, 2023
Acyltransferase Domain Exchange between Two Independent Type I Polyketide Synthases in the Same Producer Strain of Macrolide AntibioticsFumitaka Kudo, Kosuke Kishikawa, Kazuma Tsuboi, et al.
IJU Case Reports|December 29, 2025
Multiple Bone Metastases From Non-Muscle Invasive Bladder Cancer Responding to Combination Therapy With Enfortumab Vedotin and Pembrolizumab: A Case ReportShin Kanemoto, Shinkuro Yamamoto, Kosuke Hino, et al.
Acta Medica Okayama|April 30, 2025
Clinical Outcomes of Neoadjuvant Paclitaxel/Cisplatin/Gemcitabine Compared with Gemcitabine/Cisplatin for Muscle-Invasive Bladder CancerTatsushi Kawada, Yasuyuki Kobayashi, Takuji Tsugawa, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2016
Structural optimization and structure-functional selectivity relationship studies of G protein-biased EP2 receptor agonistsSeiji Ogawa, Toshihide Watanabe, Kazumi Moriyuki, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of G Protein-Biased EP2 Receptor AgonistsSeiji Ogawa, Toshihide Watanabe, Isamu Sugimoto, et al.
Scientific Reports|July 27, 2025
Eosinophils as a predictive marker of treatment-related adverse events in mRCC patients treated with first-line immune-checkpoint inhibitor combination therapyTatsushi Kawada, Satoshi Katayama, Takafumi Yanagisawa, et al.
Urologic Oncology|December 21, 2023
Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumabSatoshi Katayama, Takehiro Iwata, Tasushi Kawada, et al.
Pageof 2